Fetal and Maternal Outcome in Preterm Premature Rupture of Membranes (PPROM)

NCT ID: NCT03491826

Last Updated: 2018-04-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1011 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-01-31

Study Completion Date

2014-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to compare fetal and maternal outcome in cases of PPROM before 34 weeks versus after 34 weeks.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The data will be retrieved from the archival files and analyzed

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Premature Rupture of Membrane

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ROM before 34 weeks (A)

premature rupture of membrane before 34 weeks

rupture of membrane

Intervention Type BIOLOGICAL

ROM after 34 weeks (B)

premature rupture of membrane after 34 weeks

rupture of membrane

Intervention Type BIOLOGICAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

rupture of membrane

Intervention Type BIOLOGICAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* rupture of membrane

Exclusion Criteria

* medical disorder
Minimum Eligible Age

24 Years

Maximum Eligible Age

39 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hend Mostafa Hussein Salem

UNKNOWN

Sponsor Role collaborator

sarah mohamed hassan

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

sarah mohamed hassan

lecturer of obstetrics and gynecology

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kasr El Ainiy Hospital

Cairo, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

123

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Emotional Support for Women Experiencing PPROM
NCT06262308 NOT_YET_RECRUITING NA
Digital vs. Speculum Exams for PPROM
NCT05773014 RECRUITING NA